Fig. 6.
Fig. 6. Deficiency of Bax enhances Mpl ligand–mediated hematopoietic recovery after the myelosuppressive regimen. / PEG-rmMGDF was immediately administered toBax−/− mice (Bax KO, n = 17) and wild-type (WT, B6/129 mice, usually littermates, n = 17) after lethal myelosuppression. Carrier-treated Bax−/− mice (n = 12) and wild-type mice (n = 10). Each point represents mean ± SEM.

Deficiency of Bax enhances Mpl ligand–mediated hematopoietic recovery after the myelosuppressive regimen.

PEG-rmMGDF was immediately administered toBax−/− mice (Bax KO, n = 17) and wild-type (WT, B6/129 mice, usually littermates, n = 17) after lethal myelosuppression. Carrier-treated Bax−/− mice (n = 12) and wild-type mice (n = 10). Each point represents mean ± SEM.

Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal